期刊文献+

老年高血压病患者血vWF、GMP-140、CRP含量的研究 被引量:8

Study of the concentrations of plasma vWF,GMP-140 and serum CRP in elderly hypertensive patients
暂未订购
导出
摘要 目的 :研究老年高血压病 (EH)患者的血管内皮细胞损伤、血小板活化和炎症因子改变。方法 :选择 31例 、 期 EH患者和 2 8例老年正常对照者 ,测定其血浆 v WF因子、α颗粒膜蛋白 - 140 (GMP- 140 )和血清 C反应蛋白 (CRP)含量。结果 :EH组患者血浆 v WF、GMP- 140含量明显高于对照组 ;EH组血浆 v WF含量与收缩压呈正相关。结论 : 、 期老年 EH患者有明显的内皮细胞损伤和血小板活化 ,血管内皮细胞损伤与收缩压呈正相关。 Objective:To investigate the changes of endothelial dysfunction,platelet activation and inflammation factor in elderly hypertensive(EH) patients.Methods:Thirty\|one patients with EH in stage Ⅰ-Ⅱ and 28 elderly healthy controls were selected as subjects,their plasma concentrations of vWF,GMP-140 and serum concentrations of CRP were examined.Results:Plasma vWF and GMP-140 levels were higher in EH patients than its of control group.Level of vWF was positive correlated with systolic pressure.Conclusion:This study suggests that stage Ⅰ-Ⅱ of EH patients have significant endothelial dysfunction and platelet activation.Endothelial dysfunction is positive correlated with systolic pressure.
出处 《心血管康复医学杂志》 CAS 2001年第1期24-26,共3页 Chinese Journal of Cardiovascular Rehabilitation Medicine
关键词 老年人 高血压病 Von WILLEBRAND因子 VWF Α颗粒膜蛋白-140 GMP C反应蛋白 CRP Elderly Hypertension Von Willebrand factor(vWF) α\|granule membrane protein\|140(GMP\|140) C\|reactive protein(CRP)
  • 相关文献

参考文献12

  • 1MacMahon S, Peto R, Collins R, et al. Blood presure, stroke and coronary heart disease. Part 1. Prolonged difference in blood pressure; prospective observational studies corrected for the regression dilutionbias [J]. Lancet, 1990, 335: 765-774.
  • 2Blann AD, Naqui T, Waite M, et al. Von Willebrand factor antigen and fibronectin in essential hypertension [J]. Thromb Res, 1995,79: 331-336.
  • 3Lip GYH, Blann AD, Zarifis J, et al. Soluble adhesion molecule P-selectin and endothelial dysfunction in essential hypertension: implications for atherogenesis? A preliminary report [J]. J Hypertens, 1995, 13: 1674-1678.
  • 4Verhaar MC, Beutler J J, Gailiard CA, et al. Progressive vascular damage in hypertension is associated with increased levels of circulating P-selectin [J]. J Hypertens, 1998, 16: 45-50.
  • 5Blann AD,Waite MA. yon Willebrand factor and soluble E-selectin in hypertension: influence of treatment and value in predicting the progression of atherosclerosis [J]. Coronary Artery Dis, 1996, 7: 143-147.
  • 6Andrioli G, Ortolani R, Fontana L, et al. Study of platelet adhesion in patients with uncomplicated hypertension [J]. J Hypertens, 1996, 14: 1215-1221.
  • 7Lip GYH, Blann AD, Jones AF, et al. Relation of endothelium, thrombogenesis, and hemorheology in systemic hypertension to eth nicity and left ventricular hypertrophy [J]. Am J Cardiol, 1997, 80: 1566-1571.
  • 8Grau AJ, Buggle F, Becher H, et al. The association of leukocyte count, fibrinogen and C-reactive protein with vascular risk factors and ischemic vascular diseases [J]. Thromb Res, 1996, 82:245-255.
  • 9Dalekos GN, Elisaf M, Bairaktari E, et al. Increased serum levels of interleukin-1β in the systemic circulation of patients with essential hypertension: additional risk factor for atherogenesis in hypertensive patients [J]? J. Lab Clin Med, 1997, 129: 300- 308.
  • 10费瑜 陈丽娟 李树岩.高血压病患者肿瘤坏死因子的含量变化及临床意义[J].临床心血管病杂志,1997,13:305-305.

共引文献2

同被引文献413

引证文献8

二级引证文献88

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部